{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:46:44Z","timestamp":1782902804884,"version":"3.54.5"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In forensic toxicology (FT), drug of abuse (DoA) screening is essential yet challenging. This study presents a vendor-based, high-resolution (HR) LC\u2013MS\/MS blood screening method implemented without in\u2011house optimization, in comparison to immunoassay-based and low-resolution (LR) urine screening approaches simultaneous to (semi)quantification. The HR-method allows detection of more than 3000 analytes, including DoAs, drugs and suspected new psychoactive substances (NPS). Following protein precipitation, analytes qualitatively identified in 500 authentic whole-blood samples using the HR-method were qualitatively compared with results from the immunoassay and LR urine screening. Additionally, 82 common DoAs and drugs were (semi)quantitatively validated according to ANSI and GTFCh guidelines and quantitative performance was assessed against a fully validated targeted LC\u2013MS\/MS method (MRM mode). In total, the HR-method detected 819 (83%) of the 994 analytes identified by the LR urine screening. Substances not captured by the HR approach typically showed concentrations below the identification limit and\/or were of negligible relevance in FT. The HR blood screening detected 66% of all cases positive for THC and\/or its metabolites, whereas the LR urine screening failed to detect these compounds entirely. Incorporation of the HighResNPS\u00ae database enabled the tentative identification of 14 NPS. Seventy-four (90%) of the 82 DoAs demonstrated accuracy within \u00b1 30%, precision (CV) \u2264 30% and quantitative results of 100 authentic cases were consistent with those from the targeted LC\u2013MS\/MS method which is generally considered the gold standard for quantification. Overall, the HR blood screening is superior to the LR urine screening for most analyte classes, enabling simultaneous detection of DoAs, their metabolites and NPS. The semi-quantitative validation of 74 drugs and the quantitative comparison confirmed the method\u2019s reliability in distinguishing between subtherapeutic, therapeutic and toxic concentrations without the need for drug class-specific optimization, thereby saving time, effort and costs. This untargeted approach combines screening with (semi)quantification while supporting routine workflows, research applications and retrospective analysis of new emerging substances.<\/jats:p>","DOI":"10.1093\/jat\/bkag050","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:15:01Z","timestamp":1781612101000},"source":"Crossref","is-referenced-by-count":0,"title":["Performance evaluation of a commercial LC\u2013high-resolution-MS platform for untargeted whole blood analysis: comparison with immunoassay and LC\u2013low-resolution-MS urine screening and targeted LC\u2013MS\/MS  whole blood quantification"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1420-9751","authenticated-orcid":false,"given":"Annina","family":"Bovens","sequence":"first","affiliation":[{"name":"Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich , Zurich, CH-8057,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-2671","authenticated-orcid":false,"given":"Lana","family":"Brockbals","sequence":"additional","affiliation":[{"name":"Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich , Zurich, CH-8057,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-606X","authenticated-orcid":false,"given":"Thomas","family":"Kraemer","sequence":"additional","affiliation":[{"name":"Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich , Zurich, CH-8057,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8983-2353","authenticated-orcid":false,"given":"Andrea E","family":"Steuer","sequence":"additional","affiliation":[{"name":"Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich , Zurich, CH-8057,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2026063015322902600_bkag050-B1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/dta.1683","article-title":"Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry in post-mortem urine","volume":"7","author":"Sundstrom","year":"2015","journal-title":"Drug Test Anal"},{"key":"2026063015322902600_bkag050-B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4065\/83.1.66","article-title":"Urine drug screening: practical guide for clinicians","volume":"83","author":"Moeller","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2026063015322902600_bkag050-B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00216-010-4398-9","article-title":"Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants","volume":"400","author":"Wissenbach","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"2026063015322902600_bkag050-B4","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1007\/s00216-011-5032-1","article-title":"Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept","volume":"400","author":"Wissenbach","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"2026063015322902600_bkag050-B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clinms.2017.08.002","article-title":"Detection of drugs of abuse in urine using the Bruker Toxtyper: experiences in a routine clinical laboratory setting","volume":"4\u20135","author":"Ott","year":"2017","journal-title":"Clin Mass Spectrom"},{"key":"2026063015322902600_bkag050-B6","volume-title":"LC-MSn Library of Drugs, Poisons, and Their Metabolites","author":"Maruer HH","year":"2019","edition":"2nd edn"},{"key":"2026063015322902600_bkag050-B7","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00204-016-1764-1","article-title":"High-resolution mass spectrometry in toxicology: current status and future perspectives","volume":"90","author":"Maurer","year":"2016","journal-title":"Arch Toxicol"},{"key":"2026063015322902600_bkag050-B8","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1007\/s00216-013-7272-8","article-title":"A high-sensitivity ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine","volume":"405","author":"Sundstrom","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"2026063015322902600_bkag050-B9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.aca.2015.08.018","article-title":"Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening\u2013exemplified for cardiovascular drugs","volume":"891","author":"Helfer","year":"2015","journal-title":"Anal Chim Acta"},{"key":"2026063015322902600_bkag050-B10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1373\/clinchem.2014.222976","article-title":"Liquid chromatography high-resolution TOF analysis: investigation of MSE for broad-spectrum drug screening","volume":"60","author":"Chindarkar","year":"2014","journal-title":"Clin Chem"},{"key":"2026063015322902600_bkag050-B11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/jat\/bkt083","article-title":"Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry","volume":"37","author":"Tsai","year":"2013","journal-title":"J Anal Toxicol"},{"key":"2026063015322902600_bkag050-B12","doi-asserted-by":"publisher","first-page":"8773","DOI":"10.1007\/s00216-015-9036-0","article-title":"A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples","volume":"407","author":"Kinyua","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"2026063015322902600_bkag050-B13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/jat\/bkx108","article-title":"A validated method for the screening of 320 forensically significant compounds in blood by LC\/QTOF, with simultaneous quantification of selected compounds","volume":"42","author":"Partridge","year":"2018","journal-title":"J Anal Toxicol"},{"key":"2026063015322902600_bkag050-B14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/dta.1442","article-title":"Screening of 30 acidic and neutral pharmaceuticals in whole blood by fully automated SPE and UPLC-TOF-MS(E)","volume":"5","author":"Dalsgaard","year":"2013","journal-title":"Drug Test Anal"},{"key":"2026063015322902600_bkag050-B15","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/jssc.201200921","article-title":"Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition","volume":"36","author":"Pedersen","year":"2013","journal-title":"J Sep Sci"},{"key":"2026063015322902600_bkag050-B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jat\/bku144","article-title":"Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry","volume":"39","author":"Pasin","year":"2015","journal-title":"J Anal Toxicol"},{"key":"2026063015322902600_bkag050-B17","doi-asserted-by":"publisher","first-page":"9437","DOI":"10.1007\/s00216-013-7386-z","article-title":"Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry","volume":"405","author":"Concheiro","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"2026063015322902600_bkag050-B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.chroma.2015.04.002","article-title":"Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching","volume":"1397","author":"Concheiro","year":"2015","journal-title":"J Chromatogr A"},{"key":"2026063015322902600_bkag050-B19","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1021\/acs.analchem.5b02031","article-title":"Liquid chromatography, in combination with a quadrupole time-of-flight instrument, with sequential window acquisition of all theoretical fragment-ion spectra acquisition: validated quantification of 39 antidepressants in whole blood as part of a simultaneous screening and quantification procedure","volume":"87","author":"Roemmelt","year":"2015","journal-title":"Anal Chem"},{"key":"2026063015322902600_bkag050-B20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/FTD.0000000000000059","article-title":"Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry","volume":"36","author":"Gous","year":"2014","journal-title":"Ther Drug Monit"},{"key":"2026063015322902600_bkag050-B21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/jat\/bkaf036","article-title":"From promise to practice: why HRMS has yet to fully revolutionize forensic toxicology","volume":"49","author":"Rodda","year":"2025","journal-title":"J Anal Toxicol"},{"key":"2026063015322902600_bkag050-B22","doi-asserted-by":"publisher","first-page":"868532","DOI":"10.3389\/fchem.2022.868532","article-title":"A new strategy for efficient retrospective data analyses for designer benzodiazepines in large LC-HRMS datasets","volume":"10","author":"Pan","year":"2022","journal-title":"Front Chem"},{"key":"2026063015322902600_bkag050-B23","doi-asserted-by":"publisher","first-page":"339035","DOI":"10.1016\/j.aca.2021.339035","article-title":"Development of a single retention time prediction model integrating multiple liquid chromatography systems: application to new psychoactive substances","volume":"1184","author":"Pasin","year":"2021","journal-title":"Anal Chim Acta"},{"key":"2026063015322902600_bkag050-B24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/dta.3794","article-title":"Multianalyte approach-including automated preparation of calibrators-for validated quantification of 82 drugs in whole blood by liquid chromatography-tandem mass spectrometry","volume":"17","author":"Steuer","year":"2025","journal-title":"Drug Test Anal"},{"key":"2026063015322902600_bkag050-B25","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/dta.3861","article-title":"Evaluation of bladder wash as an alternative specimen for postmortem toxicology: comparison to screening results of urine and kidney tissue","volume":"17","author":"Steuer","year":"2025","journal-title":"Drug Test Anal"},{"key":"2026063015322902600_bkag050-B26","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1038\/s41598-026-34985-w","article-title":"Comparison of human metabolome changes identified in a placebo-controlled amphetamine administration study versus those using forensic toxicology routine data","volume":"16","author":"Bovens","year":"2026","journal-title":"Sci Rep"},{"key":"2026063015322902600_bkag050-B27","first-page":"142","article-title":"Anhang B zur Richtlinie der GTFCh zur Qualit\u00e4tssicherung bei forensisch-toxikologischen Untersuchungen Anforderungen an die Validierung von Analysenmethoden","volume":"76","author":"F.T. Peters","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"2026063015322902600_bkag050-B28","volume-title":"Standard Practices for Method Validation in Forensic Toxicology","author":"Standards","year":"2019"},{"key":"2026063015322902600_bkag050-B29","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"2026063015322902600_bkag050-B30","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"key":"2026063015322902600_bkag050-B31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/dta.2543","article-title":"Retrospective analysis for valproate screening targets with liquid chromatography-high resolution mass spectrometry with positive electrospray ionization: an omics-based approach","volume":"11","author":"Mollerup","year":"2019","journal-title":"Drug Test Anal"},{"key":"2026063015322902600_bkag050-B32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00414-012-0696-4","article-title":"Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots","volume":"127","author":"Jantos","year":"2013","journal-title":"Int J Legal Med"},{"key":"2026063015322902600_bkag050-B33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11419-022-00613-1","article-title":"Long-term stability of 24 synthetic cannabinoid metabolites spiked into whole blood and urine for up to 168 days, and the comparable study for the 6 metabolites in non-spiked real case specimens stored for 1-5 years","volume":"40","author":"Minakata","year":"2022","journal-title":"Forensic Toxicol"},{"key":"2026063015322902600_bkag050-B34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jms.3279","article-title":"Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics","volume":"48","author":"Moosmann","year":"2013","journal-title":"J Mass Spectrom"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag050\/68537228\/bkag050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/6\/bkag050\/68537228\/bkag050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/6\/bkag050\/68537228\/bkag050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:13:47Z","timestamp":1782900827000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag050\/8709242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag050","relation":{},"ISSN":["1945-2403"],"issn-type":[{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"bkag050"}}